ChemicalBook > CAS DataBase List > Aprepitant-d4
Aprepitant-d4
- Product Name
- Aprepitant-d4
- CAS No.
- 1133387-60-6
- Chemical Name
- Aprepitant-d4
- Synonyms
- Aprepitant-d4;[2H4]-Aprepitant;5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl-2,3,5,6-d4)morpholino)methyl)-2,4-dihydro-3H-1,2,4-triazol-3-one;5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(2,3,5,6-tetradeuterio-4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one;Aprepitant D4Q: What is Aprepitant D4 Q: What is the CAS Number of Aprepitant D4 Q: What is the storage condition of Aprepitant D4 Q: What are the applications of Aprepitant D4
- CBNumber
- CB02104032
- Molecular Formula
- C23H17D4F7N4O3
- Formula Weight
- 538.451309512
- MOL File
- 1133387-60-6.mol
More
Less
Aprepitant-d4 Property
- Melting point:
- 242-244°C
- storage temp.
- -20°C Freezer
- solubility
- DMSO (Slightly), Methanol (Slightly, Sonicated)
- form
- Solid
- color
- White to Off-White
More
Less
N-Bromosuccinimide Price
Cayman Chemical
- Product number
- 25232
- Product name
- Aprepitant-d4
- Purity
- ≥99% deuterated forms (d1-d4)
- Packaging
- 500μg
- Price
- $194
- Updated
- 2021/12/16
Cayman Chemical
- Product number
- 25232
- Product name
- Aprepitant-d4
- Purity
- ≥99% deuterated forms (d1-d4)
- Packaging
- 1mg
- Price
- $349
- Updated
- 2021/12/16
TRC
- Product number
- A729803
- Product name
- Aprepitant-d4
- Packaging
- 1mg
- Price
- $215
- Updated
- 2021/12/16
TRC
- Product number
- A729803
- Product name
- Aprepitant-d4
- Packaging
- 10mg
- Price
- $1695
- Updated
- 2021/12/16
American Custom Chemicals Corporation
- Product number
- RDL0006664
- Product name
- APREPITANT-D4
- Purity
- 95.00%
- Packaging
- 5MG
- Price
- $502.01
- Updated
- 2021/12/16
More
Less
Aprepitant-d4 Chemical Properties,Usage,Production
Uses
Aprepitant-d4 is a labeled analogue of Aprepitant (A729800), A novel selective neurokinin-1 (NK-1) receptor antagonist. In vitro studies using human liver microsomes indicate that Aprepitant is metabolised primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19, and no metabolism by CYP2D6, CYP2C9, or CYP2E1. Aprepitant-d4 is a potential treatment for chemotherapy induced nausea and vomiting.
Aprepitant-d4 Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less